why choose us

First received: October 06, 2023

Clinical Trial: Personalized Accelerated ChEmoRadiation (PACER) for Lung Cancer

Study Status: Completed

Recruit Status: RECRUITING

Condition: Lung Cancer

Study Type: INTERVENTIONAL


Official Title: Phase I Trial of Personalized Accelerated ChEmoRadiation (PACER) for Lung Cancer

Brief Summary: The purpose of this study is to examine the use of hypofractionated accelerated radiation therapy (HART) to treat locally advanced lung cancer.Depending on the location and size of the tumor.

Read more